Nephrolithiasis. Nephrolithiasis
Conditions
Interventions
Intervention 1: Intervention group: at the end of percutaneous nephrolithotomy, 30 cc of 0.25% bupivacaine will be injected around the nephrostomy tube. Intervention 2: control group: at the end of pe
Treatment - Drugs
Intervention group: at the end of percutaneous nephrolithotomy, 30 cc of 0.25% bupivacaine will be injected around the nephrostomy tube
control group: at the end of percutaneous nephrolithotomy, 30 cc of normal saline will be injected around the nephrostomy tube
Sponsors
Vice-chancellor for research and tech, Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with kidney stone who are candidate for after percutaneous nephrolithotomy and in age range of 18 to 60 years old. Exclusion criteria: cardiovascular disease; Bupivacaine hypersensitivity; renal or skeletal anomalies.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of pain. Timepoint: At 0, 2, 4, 6, 8 and 24 hours after the surgery. Method of measurement: Based on pain visual analog scale which is filled by the patient from 0 to 10.;The amount of pethidine used. Timepoint: At 0, 2, 4, 6, 8 and 25 hours after the surgery. Method of measurement: The amount of used drug in miligram. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: 24 hours after the surgery. Method of measurement: Any changes in blood pressure and cardiac arrhythmias. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Dinyar Khazaeli
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed